基于单细胞转录组学的新辅助免疫联合化疗治疗后肺鳞癌患者肿瘤免疫微环境特征的初步分析OA
Preliminary Analysis of Tumor Immune Microenvironment Characteristics in Lung Squamous Cell Carcinoma after Neoadjuvant Immunochemotherapy Based on Single-cell Transcriptomics
背景与目的 新辅助免疫联合化疗是非小细胞肺癌(non-small cell lung cancer,NSCLC)的重要治疗策略,但患者治疗反应异质性显著,目前疗效评估多依赖影像学检查,对治疗后肿瘤微环境(tumor microenvironment,TME)变化及其与疗效的关联仍缺乏足够的研究.本研究应用单细胞RNA测序(single-cell RNA sequencing,scRNA-seq)技术解析新辅助免疫联合化疗后肺鳞癌TME重塑特征,探讨其与疗效差异的潜在关系.方法 对2例接受新辅助免疫联合化疗后手术切除的肺鳞癌患者肿瘤组织进行scRNA-seq,整合分析TME的细胞组成、功能状态及细胞间通讯特征.结果 术前影像学评估病例1呈现部分缓解(partial response,PR)、病例2为疾病稳定(stable disease,SD)状态;术后病理评估分别为主要病理缓解(major pathological response,MPR)和部分病理缓解(partial pathological response,PPR).scRNA-seq分析共鉴定出9种主要细胞群.2例患者TME存在明显异质性:病例1呈免疫细胞富集和炎症激活特征;病例2以髓系及内皮信号重塑为主,伴更明显的免疫调节和血管生成特征.细胞通讯分析显示,病例1以炎症趋化相关互作为主,病例2则表现为CXC趋化因子(C-X-C motif chemokine ligand,CXCL)、分泌型磷蛋白1(secreted phosphoprotein 1,SPP1)、血管内皮生长因子(vascular endothelial growth factor,VEGF)、巨噬细胞移动抑制因子(macrophage migration inhibitory factor,MIF)和肿瘤坏死因子(tumor necrosis factor,TNF)等信号增强,并突出免疫抑制相关互作轴;同时,病例2中巨噬细胞相对富集,T细胞耗竭特征更明显.结论 新辅助免疫联合化疗后肺鳞癌患者TME在细胞组成、功能状态及细胞通讯层面存在显著异质性,scRNA-seq揭示的TME重塑模式可为理解疗效评估差异、探索潜在生物标志物提供线索.
Background and objective Neoadjuvant immunochemotherapy has emerged as an important treat-ment strategy for non-small cell lung cancer(NSCLC);however,substantial heterogeneity in therapeutic response persists among patients.Currently,treatment efficacy is primarily evaluated by imaging modalities,and there remains a lack of com-prehensive studies investigating post-treatment alterations in the tumor microenvironment(TME)and their association with clinical response.This study applied single-cell RNA sequencing(scRNA-seq)to characterize TME remodeling in lung squamous cell carcinoma after neoadjuvant immunochemotherapy and to explore its potential association with differences in therapeutic response.Methods Tumor specimens from two patients with lung squamous cell carcinoma who underwent surgical resection following neoadjuvant immunochemotherapy were subjected to scRNA-seq.An integrated analysis was per-formed to characterize the cellular composition,functional states,and intercellular communication patterns within the TME.Results Preoperative imaging evaluation indicated partial response(PR)in patient 1 and stable disease(SD)in patient 2,whereas postoperative pathological evaluation showed major pathological response(MPR)and partial pathological response(PPR),respectively.ScRNA-seq identified nine major cell populations.The TME exhibited marked heterogeneity between the two patients:patient 1 was characterized by immune cell enrichment and inflammatory activation,whereas patient 2 showed remodeling dominated by myeloid and endothelial signals,together with more prominent immune regulatory and angiogenic features.Cell-cell communication analysis revealed that patient 1 was mainly characterized by inflammatory chemotactic inter-actions,whereas patient 2 showed enhanced C-X-C motif chemokine ligand(CXCL),secreted phosphoprotein 1(SPP1),vascular endothelial growth factor(VEGF),macrophage migration inhibitory factor(MIF)and tumor necrosis factor(TNF)signaling,along with prominent immunosuppressive interaction axes.In addition,patient 2 showed a relative enrichment of macrophages and a more pronounced exhausted T-cell phenotype.Conclusion After neoadjuvant immunochemotherapy,the TME in pa-tients with lung squamous cell carcinoma exhibits marked heterogeneity in terms of cellular composition,functional states,and intercellular communication.The TME remodeling patterns revealed by scRNA-seq may provide insights into discrepancies in treatment response evaluation and help identify potential biomarkers.
汪冠男;刘红雨;陈军;王亚楠;刘京豪;刘明辉;李宣广;张子禾;张洪兵;华钰;李永文
300052 天津,天津医科大学总医院胸部肿瘤中心,肺部肿瘤外科天津医科大学总医院,天津市肺癌研究所,天津市肺癌转移与肿瘤微环境重点实验室300052 天津,天津医科大学总医院胸部肿瘤中心,肺部肿瘤外科||天津医科大学总医院,天津市肺癌研究所,天津市肺癌转移与肿瘤微环境重点实验室300052 天津,天津医科大学总医院胸部肿瘤中心,肺部肿瘤外科300052 天津,天津医科大学总医院胸部肿瘤中心,肺部肿瘤外科300052 天津,天津医科大学总医院胸部肿瘤中心,肺部肿瘤外科300052 天津,天津医科大学总医院胸部肿瘤中心,肺部肿瘤外科300052 天津,天津医科大学总医院胸部肿瘤中心,肺部肿瘤外科300052 天津,天津医科大学总医院胸部肿瘤中心,肺部肿瘤外科300052 天津,天津医科大学总医院胸部肿瘤中心,肺部肿瘤外科天津医科大学总医院,天津市肺癌研究所,天津市肺癌转移与肿瘤微环境重点实验室
肺肿瘤单细胞测序新辅助治疗肿瘤微环境
Lung neoplasmsSingle-cell sequencingNeoadjuvant therapyTumor microenvironment
《中国肺癌杂志》 2026 (3)
168-179,12
本研究受国家科技重大专项(No.2025ZD0544700)、国家自然科学基金项目(No.82473191)、天津市重点医学学科建设项目(No.TJYXZDXK-3-002B,No.TJYXZDXK-3-006A-2)、天津市自然科学基金项目(No.23JCZDJC00710,No.24JCYBJC00330,No.23JCYBJC01010,No.25JCLZIC00230)以及国家高水平医院临床研究经费项目(No.LC2024L01)资助 This paper was supported by the grants from National Science and Technology Major Project(No.2025ZD0544700,to Jun CHEN),National Natural Science Foundation of China(No.82473191,to Jun CHEN),Tianjin Key Medical Discipline Construction Project(No.TJYXZDXK-3-002B,to Jun CHENNo.TJYXZDXK-3-006A-2,to Jun CHEN),Natural Science Foundation of Tianjin(No.23JCZDJC00710,to Jun CHENNo.24JCYBJC00330,to Hongyu LIUNo.23JCYBJC01010,to Yongwen LINo.25JCLZIC00230,to Hongbing ZHANG)and National High Level Hospital Clinical Research Funding(No.LC2024L01,to Hongyu LIU).
评论